Influenza A Virus Subtype Differentiation Nucleic Acid Assay
OEP · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3980
Classification
FDA Product Code
OEP
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3980
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
A qualitative in vitro diagnostic assay intended to detect and differentiate between influenza a virus subtypes in human respiratory specimens or viral culture. Detection and differentiation of specific subtype rna aids in the diagnosis of influenza caused by influenza a in conjunction with other clinical and laboratory testing in patients suspected of being infected with these viruses. Also, it aids in the presumptive laboratory identification of influenza a virus subtypes to provide epidemiological information on influenza.